Treatment of restless legs syndrome with subcutaneous apomorphine in a patient with short bowel syndrome.
Tings
T
T
Stiens
G
G
Paulus
W
W
Trenkwalder
C
C
Happe
S
S
D000328:Adult; D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000379:methods; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000209:etiology; D012778:Short Bowel Syndrome / Q000150:complications / Q000188:drug therapy*
D018491:Dopamine Agonists; D001058:Apomorphine
Neuropsychobiology. 2003;48(2):82-6
14504416
Neurophysiol Clin. 2003 Sep;33(4):180-4
14519546
Acta Neurol Scand. 1999 Sep;100(3):163-7
10478579
Sleep Med. 2003 Mar;4(2):101-19
14592341
Mov Disord. 1995 Sep;10(5):634-42
8552117
CNS Drugs. 2004;18(1):27-36
14731057
J Clin Neurophysiol. 2001 Mar;18(2):128-47
11435804
Sleep Med. 2003 Mar;4(2):121-32
14592342